Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Forza Innovations's 3-Year RORE % for the quarter that ended in Dec. 2023 was 0.00%.
The industry rank for Forza Innovations's 3-Year RORE % or its related term are showing as below:
FORZ's 3-Year RORE % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -4.17 * Ranked among companies with meaningful 3-Year RORE % only.
Forza Innovations (OTCPK:FORZ) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Forza Innovations 3-Year RORE % Related Terms
Forza Innovations 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Forza Innovations's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FORZ vs USAQ, EMED, RTSL: 3-Year RORE % Comparison
For the Medical Devices subindustry, Forza Innovations's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Forza Innovations 3-Year RORE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Forza Innovations's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Forza Innovations's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2023 and 3-year before.
Forza Innovations (FORZ) has a 3-Year RORE % of 0.00 as of Dec. 2023. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Forza Innovations and its competitors.
Is Forza Innovations' 3-Year RORE % too high?
Forza Innovations' current 3-Year RORE % is 0.00.
How does Forza Innovations' 3-Year RORE % compare to USAQ and EMED?
Forza Innovations' 3-Year RORE % of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Forza Innovations and its competitors. Forza Innovations's current 3-Year RORE % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Forza Innovations stock overvalued right now?
Forza Innovations (FORZ) has a current 3-Year RORE % of 0.00. The current 3-Year RORE % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Forza Innovations (FORZ), the current 3-Year RORE % is 0.00 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Forza Innovations Inc is in the health-tech wearable performance business. The company has acquired all the ownership and rights to certain late developmental-stage products, including the J4 Sport, J4 X, and J4 Fitbelt. These products are wearable back compression devices, used to relax, warm up, loosen, or relax stiff & sore muscles. The therapeutic application of heat causes a change in the temperature of the soft tissues which decreases joint stiffness and relieves inflammation.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FORZ has been successfully added to your 